Biostar Pharmaceuticals, Inc. (BSPM)

[gpg]

Per the 11/3/09 8-K regarding uplisting and penalty for missing deadline for uplisting to major exchange:

The Company has agreed that if its common stock is not listed on a national securities exchange within one hundred and forty-five (145) days of the Closing Date, the Company shall pay the Investors as liquidated damages and not as a penalty, an amount equal to twelve percent (12%) per annum, based on the lesser of (i) the Purchase Price or (ii) that percentage of the Purchase Price which the shares of common stock issuable upon conversion of the Series B Preferred Stock and issuable upon exercise of the Warrants (the "Underlying Shares") bears to the number of shares of common stock initially issuable upon conversion of the Series B Preferred Stock, provided, however, such payment of liquidated damages shall not accrue until the Company fulfills all of its requirements for listing on a national securities exchange.